(Q38074839)

28 August 2017

1 reference

title

Gender differences in Parkinson's disease: focus on plasma α-synuclein (English)

1 reference

28 August 2017

1 reference

1 reference

8

Nicola Vanacore

1 reference

28 August 2017

Anna Traficante

4

0 references

Paola Piscopo

object named as

Paola Piscopo

2

0 references

Roberto Rivabene

object named as

Roberto Rivabene

3

0 references

Annamaria Confaloni

object named as

Annamaria Confaloni

9

0 references

author name string

Giovanni Caranci

1

1 reference

28 August 2017

Barbara Riozzi

5

1 reference

28 August 2017

Anna Elisa Castellano

6

1 reference

28 August 2017

Stefano Ruggieri

7

1 reference

28 August 2017

publication date

18 January 2013

1 reference

Journal of Neural Transmission

28 August 2017

published in

1 reference

28 August 2017

volume

120

1 reference

28 August 2017

issue

8

1 reference

28 August 2017

page(s)

1209-1215

1 reference

Red blood cells are the major source of alpha-synuclein in blood.

28 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-0972-6

Effects of gender on nigral gene expression and parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-0972-6

Alpha-synuclein targets the plasma membrane via the secretory pathway and induces toxicity in yeast

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-0972-6

Plasma alpha-synuclein in patients with Parkinson's disease with and without treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-0972-6

Cell-produced alpha-synuclein is secreted in a calcium-dependent manner by exosomes and impacts neuronal survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-0972-6

Phosphorylated α-synuclein can be detected in blood plasma and is potentially a useful biomarker for Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-0972-6

Anti-aggregation and fibril-destabilizing effects of sex hormones on alpha-synuclein fibrils in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-0972-6

DJ-1 and alpha-synuclein in human cerebrospinal fluid as biomarkers of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-0972-6

Intravesicular localization and exocytosis of alpha-synuclein and its aggregates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-0972-6

The plasma alpha-synuclein levels in patients with Parkinson's disease and multiple system atrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-0972-6

Plasma alpha-synuclein is decreased in subjects with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-0972-6

The oxysterol 27-hydroxycholesterol regulates α-synuclein and tyrosine hydroxylase expression levels in human neuroblastoma cells through modulation of liver X receptors and estrogen receptors--relevance to Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-0972-6

α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-0972-6

Elevated levels of α-synuclein oligomer in the cerebrospinal fluid of drug-naïve patients with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-0972-6

REM sleep behaviour disorder in Parkinson's disease: a questionnaire-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-0972-6

Significance and confounders of peripheral DJ-1 and alpha-synuclein in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-0972-6

Alzheimer's disease, normal-pressure hydrocephalus, and senescent changes in CSF circulatory physiology: a hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-0972-6

Evidence for gender-specific transcriptional profiles of nigral dopamine neurons in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-0972-6

Decreased alpha-synuclein in cerebrospinal fluid of aged individuals and subjects with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-0972-6

Parkinson's disease with and without REM sleep behaviour disorder: are there any clinical differences?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-0972-6

Alpha-synuclein implicated in Parkinson's disease is present in extracellular biological fluids, including human plasma

21 January 2018

1 reference

12 December 2020

Neuropathology and neurochemistry of nonmotor symptoms in Parkinson's disease

1 reference

12 December 2020

Skin and platelet alpha-synuclein as peripheral biomarkers of Parkinson's disease

1 reference

12 December 2020

Non-classical exocytosis of alpha-synuclein is sensitive to folding states and promoted under stress conditions

1 reference

12 December 2020

Detection of oligomeric forms of alpha-synuclein protein in human plasma as a potential biomarker for Parkinson's disease

1 reference

12 December 2020

Alpha-synuclein mRNA expression in sporadic Parkinson's disease

1 reference

12 December 2020

Lymphomonocyte alpha-synuclein levels in aging and in Parkinson disease

1 reference

12 December 2020

10.1007/S00702-013-0972-6

Identifiers

DOI

1 reference

28 August 2017

1 reference